Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.

By M. Kazatchkine, S. Kaveri. New England Journal of Medicine, 2001

1,217 citations recorded by the source corpus.

Subfields: Genetics, Immunology, Neurology

View Paper: https://www.semanticscholar.org/paper/458804ffc2dd8b2a5c7ef98d8953d6870cadfb44

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. Y. Bryceson

Citations in the corpus

• THE 2021 EUROPEAN GROUP ON GRAVES' ORBITOPATHY (EUGOGO) CLINICAL PRACTICE GUIDELINES FOR THE MEDICAL MANAGEMENT OF GRAVES' ORBITOPATHY. (2021, positive): “Intravenous immunoglobulin treatment resulted in decreased specific autoantibody titers and clinical improvement in several autoimmune diseases (152).”
• The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 (2020, positive): “The hypothesis that autoantibodies contribute to the pathology in MIS-C is supported by the efficacy of intravenous immunoglobulin in MIS-C, a common approach to activate inhibitory Fc-receptors and prevent membrane-attack complexes by complement factors and thereby mitigating autoantibody-mediated ”